Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain ...
The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found. The ...
A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study shows. Liraglutide lowered body mass, ...
New M&S salads, breads, yoghurt bowls and chicken dinners come as more Britons turn to Mounjaro and Wegovy ...
Startups are raising millions to build businesses around drugs like Ozempic and Wegovy, as they chase a market set to surge to $90 billion.
Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results